Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis: The BE RADIANT Randomized Clinical Trial With Open-Label Extension
{{output}}
Importance: Patient-reported outcome (PRO) assessments alongside clinical parameters help to holistically determine treatment benefits. Objective: ... ...
